Comparison and Analysis between the NAV6 Embolic Protection Filter and SpiderFX EPD Filter in Superficial Femoral Artery Lesions

Table 4

Major adverse events.

% (n/N)	Emboshield NAV6 (N = 161)	SpiderFX EPD (N = 346)	value
Freedom from MAE	92.0% (149/161)	91.6% (317/346)	0.721
Death	0.6% (1/161)	0.3% (1/346)	0.582
MI (modified ARC)	1.2% (2/161)	2.9% (10/346)	0.252
TVR	0.0% (0/161)	0.6% (2/346)	0.332
Thrombosis	0.6% (1/161)	1.2% (4/346)	0.556
Dissection (grade C or greater)	4.9% (8/161)	2.9% (10/346)	0.245
Distal embolization	0.6% (1/161)	0.9% (3/346)	0.767
Perforation at the level of the filter	0.0% (0/161)	0.0% (0/346)	N/A
Unplanned amputation	0.0% (0/161)	0.0% (0/346)	N/A

^aBy the Newcombe score method. ARC, academic research consortium; MAE, major adverse event; MI, myocardial infarction; TVR, target vessel revascularization.